A 2024 study connected certain progestogens — ingredients in some birth control medications — to an increased risk of tumors near the brain. Learn more about birth control medications and meningiomas, the type of tumor associated with these medications.
On this Page
Key takeaways about birth control and brain tumors
- Meningioma is a type of tumor that grows near the brain; most are not cancerous.
- A 2024 study linked long-term use of some progestogen-based contraceptives to an increased risk of meningioma.
- Some experts believe that women should regularly review their birth control medication options.
What is a meningioma?
A meningioma is a type of tumor that grows in the meninges. These membranes surround the brain and spinal cord. They’re typically non-cancerous (or benign), which means they won’t spread to other parts of your body.
Even though most meningiomas are benign, they can still be life-threatening if they grow large enough to affect nearby parts of the brain.
There are three types of meningioma:
- Grade 1 (typical): A slow-growing form that accounts for the majority (80%) of meningioma cases
- Grade 2 (atypical): A fast-growing tumor that may be resistant to treatment. It accounts for 17% of meningioma diagnoses.
- Grade 3 (anaplastic): A cancerous meningioma that spreads quickly. These account for less than 2% of cases.
Meningioma brain cancer risk factors
Several risk factors are associated with meningiomas:
- Age: Meningiomas are most common among people over the age of 60.
- Changes in hormones: Hormone receptors often present in meningioma cells might react to hormones like estrogen and progesterone.
- Gender: Women develop meningioma three times more frequently than men.
- Genetics: Inherited conditions, such as multiple endocrine neoplasia type 1 (MEN1), neurofibromatosis type 2 (NF2) and schwannomatosis, are linked to several types of central nervous system tumors.
- Obesity: Tumors are a risk for people who are overweight.
- Radiation treatments: People who have had radiation therapy to the head and neck may have elevated meningioma risk.
- Use of birth control drugs: Researchers reported a higher risk of developing meningioma in women using birth control methods that contained progestogens (medical drugs that mimic the natural hormone progesterone, which is related to reproductive functions).
What are the symptoms of a meningioma?
These are symptoms commonly associated with meningiomas:
- Blurred vision
- Headaches
- Hearing loss
- Memory loss
- Numbness
- Poor balance
- Seizures
- Weakness in limbs
These symptoms are often linked to the location of the meningioma.
Is a meningioma brain tumor the same as brain cancer?
No, most meningiomas are not considered brain cancer. The one exception is the Grade 3 or anaplastic type of meningioma. A Grade 3 meningioma can spread to other parts of the body.
Learn about our experience with birth control lawsuits
Motley Rice attorneys have extensive experience with birth control litigation. Our firm has represented plaintiffs in:
What birth control medications are allegedly linked to meningioma?
The main birth control medication linked to meningioma is the Depo-Provera contraceptive shot. French researchers studied more than 108,000 women who used progestogen-containing birth control medications, including injectable drugs and certain birth control pills. Progestogens are used for:
- Hormonal contraceptives
- Fertility treatments
- Preventing or managing miscarriage or premature birth
The French study evaluated several forms of widely used progestogens. Researchers used data from more than 18,000 women who had intracranial meningiomas between 2009 and 2018. They compared each case to five healthy control subjects.
They found links between use of progestogens and increased risk of meningioma. The highest-risk progestogens were:
- Medroxyprogesterone acetate (sold as Depo-Provera and other brand names): An injectable contraceptive with a 460% increase in risk
- Medrogestone (sold as Colprone and other brand names): An oral pill with a 310% increase in risk
- Promegestone (sold as Surgestone and other brand names): An oral pill with a 270% increase in risk
The study doesn’t prove that the hormones caused the tumors. It also didn’t account for other risk factors, such as exposure to radiation and genetic predisposition to meningioma.
Other brand names for medroxyprogesterone acetate birth control shots
Depo-Provera is sold under several other names, including:
- Depo-SubQ Provera 104
- Medroxyprogesterone (generic)
- Medroxyprogesterone acetate (generic)
- Provera
Birth control brain tumor lawsuits
Women who took Depo-Provera and developed meningiomas are suing Pfizer and other companies associated with the manufacturing, marketing and distribution of Depo-Provera. Plaintiffs claim that Pfizer didn’t adequately warn doctors or patients of the potential side effects.
Our women’s health experience
Our law firm has represented women in a wide range of litigation involving health, medication, medical devices and toxins. Motley Rice attorneys hold leadership roles in mass legal actions related to breast implant, hair relaxer and talcum powder lawsuits.
Learn more about our work in women’s health litigation.
Do not stop taking prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. Depo-Provera, Mirena, NuvaRing, and Paragard remain approved by the U.S. Food and Drug Administration.
Key takeaways
What is a meningioma?
What birth control medications are allegedly linked to meningioma?
Birth control brain tumor lawsuits
Our women’s health experience
- Sources
- Cleveland Clinic. Meningioma.
- The Guardian. Hormone medication could increase risk of brain tumours, French study finds.
- Johns Hopkins Medicine. Meningioma.
- Lawyer Monthly. Depo-Provera Pfizer Lawsuits Allege Link to Brain Cancer.
- Moffitt Cancer Center. Meningioma Causes and Risk Factors.
- National Toxicology Program. Progestogens and Adverse Health Outcomes.
- Roland N, Neumann A, Hoisnard L, Duranteau L, Froelich S, Zureik M et al. Use of progestogens and the risk of intracranial meningioma: national case-control study BMJ 2024; 384 :e078078 doi:10.1136/bmj-2023-078078
- WebMD. Medroxyprogesterone (Provera, Depo-Provera, and others) - Uses, Side Effects, and More.